| October 19, 2006
Dr. Susan Froshauer, President and Chief Executive Officer of Rib-X Pharmaceuticals, will present at the
The BIO InvestorForum 2006
October
16, 2006
Open
Solutions Inc. Announces Agreement
To Be Acquired By The Carlyle Group
and Providence Equity Partners
October 4, 2006
New
England Journal Of Medicine Reports
Positive Results From Dynavax' Ragweed
Allergy Therapy Trial
October 3, 2006
Qlogic
To Acquire SilverStorm Technologies
September 29 , 2005
Aspreva
Announces Achievement of Targeted
Patient Enrolment in Phase III Clinical
Trial for CellCept in Lupus Nephritis
September 14, 2006
BioMimetic
Therapeutics’ Clinical Investigators
to Receive Award from American Academy
of Periodontology for Outstanding
Publication
September 11, 2006
Tangoe
Awarded Patent on Telecommunications
Expense Management Technology
September 7, 2006
Dr.
Susan Froshauer, President and Chief
Executive Officer of Rib-X Pharmaceuticals,
will present at the Thomas Weisel
Partners 2006 Healthcare Conference
June 20, 2006
Rib-X
Pharmaceuticals Raises $50 Million
in Series C Financing
June 6, 2006
MX Logic Email Defense Service Wins 2006 Global Excellence Award From Info Security Products Guide
May 31, 2006
MX
Logic Listed Among Entrepreneur And
Pricewaterhousecoopers’ Hot
100 Fastest-Growing U.S. Companies
May 22, 2006
Small
Bone Innovations, Inc. Honored As
One Of The Nation’s Leading Technology
Companies
May 12, 2006
BioMimetic
Therapeutics, Inc. Announces Pricing
of Initial Public Offering
March 22, 2006
WellDog
Closes $6.5 Million in Funding and
Welcomes Three New Investment Partners
March 20, 2006
BioMimetic
Therapeutics Initiates Clinical Trials
with Novel Bio-active
Drug-device Combination Bone Graft
in Two Orthopedic Indications
February 13, 2006
After First Product Approval, BioMimetic Seeks $50M IPO
January 10, 2006
SilverStorm Technologies Closes $13
Million in Funding
|